Effect of tripterygiitotorum on the expressions of metalloproteinase-9 and tissue inhibitor of metalloproteinase -1 in lung tissue of asthmatic rats
Ma Xiu-qin,Huang Mao,Guo Xi-rong,Yin Kai-sheng
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.43.053
2005-01-01
Abstract:AIM: To observe the effect of tripterygiitotorum on the expression of metalloproteinase-9 and tissue inhibitor of metalloproteinase -1 in the lung of asthmatic rats. METHODS: ① The experiment was conducted in the center for Experimental Animals of Nanjing Medical University, in the laboratory of the Department of Biochemistry and Staff Room of Pathology of Nanjing Medical University from January to September 2004. Eighteen healthy male Wistar rats were selected and divided randomly into control group, asthmatic group and drug group with 6 rats in each group. ② The rats in the asthmatic group and drug group were given with 1 mL antigen suspension with intraperitoneal injection at the 1st and 8th days to sensitize. From the 15th day 10 g/L ovalbumin was sucked by pulverization to excite asthma, once a day, 20 minutes every time, for 4 weeks making asthmatic models. Before 30 minutes of excitation every day those in the drug group were treated with gastric perfusion with (1.5 mL) 50 mg/kg tripterygiitotorum in advance. Those in the control group were sensitized and excited with saline of the same volume, once a day, 20 minutes once, for 4 weeks. ③ The protein expressions of metalloproteinase-9and tissue inhibitor of metalloproteinase-1 in lung tissue were examined by immunohistochemical method. The expressions of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1mRNA in lung tissue were assessed by reverse transcription-polymerase chain reaction. ④ Comparison of mean in multiple groups was conducted with analysis of variance. Pairwise comparison among groups was done with q-test. RESULTS: Totally 18 rats were involved in the result analysis. ① Protein content of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats: It was higher significantly in the asthmatic group than that in the control group (q=9.75,7.87,P < 0.01). After intervention with drug it was lower than that in the asthmatic group (q=5.99,3.27,P < 0.05), but still higher obviously than that in the control group (q=3.76,4.59,P < 0.05). ② The ratio of metalloproteinase-9/ tissue inhibitor of metalloproteinase -1 in lung tissue of rats: It was over 1 in the asthmatic group, and higher markedly than that in the control group (q=3.87,P < 0.05). After intervention with drug, it was less than 1, and lower remarkably than that in the control group (q=3.47,P < 0.05), and even more lower than that in the asthmatic group (q=7.34,P < 0.01). ③ Expressions of metalloproteinase-9 and tissue inhibitor of metalloproteinase -1 mRNA: It was higher in the asthmatic group than that in the control group (q=16.71,15.37,P < 0.01). After intervention with drug it decreased apparently, and even distinctly lower than that in the asthmatic group (q=11.14,7.21,P < 0.01). But did not decrease to normal fully, and still clearly higher than that in the control group (q=5.57,8.17,P < 0.01). ④ Ratio of metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 mRNA of lung tissue of rats: It was more than 1 in the asthmatic group, and evidently higher than that in the control group (q=3.45,P < 0.05). After intervention with drug it was less than 1, and significantly lower than that in the control group (q=3.45,P <0.05), and even lower than that in the asthmatic group (q=6.89,P < 0.01=. CONCLUSION: Tripterygiitotorum may down-regulate the expression of metalloproteinase-9 and regulate the balance between metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and intervene the remodeling of extracllular matrix.